Trial Profile
A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs RO 6799477 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Roche
- 26 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 23 Dec 2014 Planned End Date changed from 1 Jul 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 23 Dec 2014 Planned primary completion date changed from 1 Jul 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.